Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Capital Leases (2020 - 2021)

GeneDx Holdings (WGS) has disclosed Capital Leases for 2 consecutive years, with $18.4 million as the latest value for Q4 2021.

  • On a quarterly basis, Capital Leases fell 11.31% to $18.4 million in Q4 2021 year-over-year; TTM through Dec 2021 was $18.4 million, a 11.31% decrease, with the full-year FY2021 number at $18.4 million, down 11.31% from a year prior.
  • Capital Leases was $18.4 million for Q4 2021 at GeneDx Holdings, down from $20.8 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $20.8 million in Q4 2020 to a low of $18.4 million in Q4 2021.